Imoproxifan

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameImoproxifan

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHistamine H3 receptor antagonists

TargetsHistamine H3 receptor

Therapy Area/IndicationsCognition Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBioprojet Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBioprojet Pharma

Active IndicationsN/A

Inactive IndicationsCognition Disorders

ATC CodeN/A